Daniela Haimov
Primary Care · Phoenix, AZNPI 1114523719
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 277 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Viiv Healthcare Company at 25.6% of the total. Reporting peaked in 2022 at $3,215 and has fallen 87.5% since, to $401 in 2025. Among primary care clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 277 payments — averaging $27.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$1K
- AstraZeneca$634
- Novo Nordisk$502
- AbbVie$440
- Johnson & Johnson$397
- plus $2K from 23 others
What the payments were for
- Speaking & faculty fees$340%
- Food & beverage$7,36497%
- Education$1852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 80 | $1,941 |
| Gilead | 68 | $1,420 |
| AstraZeneca(2 entities) | 9 | $634 |
| Novo Nordisk | 12 | $502 |
| AbbVie | 16 | $440 |
| Johnson & Johnson | 24 | $397 |
| Revance Therapeutics, Inc. | 3 | $384 |
| Janssen Products, LP | 3 | $301 |
| Boehringer Ingelheim | 14 | $288 |
| Merck | 11 | $214 |
| Lilly USA, LLC | 5 | $187 |
| Galderma Laboratories, L.p. | 1 | $147 |
| EMD Serono, Inc. | 7 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $112 |
| Adaptive Biotechnologies Corporation | 1 | $103 |
| Amgen | 4 | $72 |
| Sunovion Pharmaceuticals Inc. | 3 | $49 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $44 |
| Boston Scientific | 1 | $35 |
| Napo Pharmaceuticals Inc | 2 | $34 |
| Medtronic | 2 | $23 |
| Novartis | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Seqirus USA Inc | 1 | $17 |
| Lucid Diagnostics Inc. | 1 | $17 |
| Vertex | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Acerus Pharmaceuticals Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,583 in reported general payments places this provider in the 95th percentile of 151 primary care providers in Arizona.
Other primary care in Phoenix
- Trey PowrzanasPhoenix$16K
- Christine Rocks-LopezPhoenix$14K
- Elena KlimovaPhoenix$8K
- Albert VillafaniaPhoenix$8K
- Charity CorreaPhoenix$5K
- Cara Loveless-FaulknerPhoenix$4K
- Chelsea GreenwoodPhoenix$4K
- Kerry OliverPhoenix$2K
- Kathryn SuessPhoenix$2K
- Nahla ChircoPhoenix$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.